These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
33. Homocysteine as a risk factor for cardiovascular and related disease: nutritional implications. Weir DG; Scott JM Nutr Res Rev; 1998 Dec; 11(2):311-38. PubMed ID: 19094252 [TBL] [Abstract][Full Text] [Related]
34. Red blood cell methylfolate and plasma homocysteine as risk factors for venous thromboembolism: a matched case-control study. Quéré I; Perneger TV; Zittoun J; Bellet H; Gris JC; Daurès JP; Schved JF; Mercier E; Laroche JP; Dauzat M; Bounameaux H; Janbon C; de Moerloose P Lancet; 2002 Mar; 359(9308):747-52. PubMed ID: 11888585 [TBL] [Abstract][Full Text] [Related]
35. Homocysteine, vitamin status and risk of vascular disease; effects of gender and menopausal status. European COMAC Group. Verhoef P; Meleady R; Daly LE; Graham IM; Robinson K; Boers GH Eur Heart J; 1999 Sep; 20(17):1234-44. PubMed ID: 10454975 [TBL] [Abstract][Full Text] [Related]
36. Common mutation in methylenetetrahydrofolate reductase. Correlation with homocysteine and other risk factors for vascular disease. Motti C; Gnasso A; Bernardini S; Massoud R; Pastore A; Rampa P; Federici G; Cortese C Atherosclerosis; 1998 Aug; 139(2):377-83. PubMed ID: 9712345 [TBL] [Abstract][Full Text] [Related]
37. Homocysteine and cerebral ischemia: pathogenic and therapeutical implications. Pezzini A; Del Zotto E; Padovani A Curr Med Chem; 2007; 14(3):249-63. PubMed ID: 17305530 [TBL] [Abstract][Full Text] [Related]